1207 Geneva, Rue de Soleure 6

1 Supply chain management

Companies commission us to:

  • Search for and find new contract suppliers (CMO and CDMO)

  • To neutrally assess the technologies of new suppliers and make a pre-selection of potential contract manufacturers

  • Plan, budget and implement the entire outsourcing project

  • Making the supply chain more robust, reducing costs and increasing efficiency

Independent of suppliers and contract manufacturers (CMOs). Consulting and implementation.

Supply Chain Management Finding the right partner as a contract manufacturer (CMO) has far-reaching consequences for the efficiency and profitability of a product.

Relocating production to a contract manufacturer and making the necessary adjustments to the manufacturing method are relatively complex projects with numerous departments and partners involved. Regulatory requirements often come to mind, but the technical and administrative changes are also quite complex.

We are independent of suppliers and contract manufacturers and can effectively represent your points of view.

This saves you valuable time and gets you to market faster!

01/08
Process development, scale-up in the pharmaceutical industry
01/08

Supply Chain Management Outsourcing in the pharmaceutical industry is the strategic decision to manufacture products with a contract manufacturer (CMO and CDMO). There can be numerous reasons for shifting a production chain to an external supplier. The decisive factors are often

1. costs supply chain management

Contract manufacturers specialize in cost-effective and fast production.
Outsourcing to improve cost efficiency can significantly improve your competitive position

2. flexibility in production

Contract manufacturers are usually more flexible with batch sizes and have different shearing technologies at their disposal. This results in much greater flexibility in production and can lead to shorter replenishment times.

3. the production know-how is not available internally

Many products in biotechnology are developed by start-ups. Naturally, there are no or only very limited production options there. Contract manufacturing is the only way to produce industrial quantities under GMP conditions and bring them to market.

Supply chain management pharmaceutical industry

1. costs and cost structure

Many companies only look at the manufacturing costs of an external supplier and make the decision to produce there based on this. But supply chain management is much more than that! However, the total costs incurred by the transfer and establishment with a contract manufacturer are decisive.

When transferring an existing production to a new supplier, costs are incurred that are usually not directly attributed to the transfer but should be considered for the overall profitability. These include, for example, the costs of technical batches at the new supplier, the adaptation of the manufacturing method to the equipment and procedures of the contract manufacturer, costs for validations, costs for changing the registration dossier and the largest cost item:

the duration of the transfer project including the costs of all departments and persons involved. Costs are incurred twice during the project period. Once in the company's own production, which has not yet been transferred, and the total transfer costs including trials in the new production facility. This period in particular, together with the associated activities, is a key factor in determining the total costs of the production transfer and the success or failure of outsourcing.

It is therefore of paramount importance that such outsourcingProduction transfer carefully planned and implemented quickly. The differences between a quick, clean production transfer and a relatively complex, multi-year project could quickly exceed millions.

Efficiency

2. flexibility in production

In general, contract manufacturers are actually optimized to produce different types of products quickly and efficiently. However, this focus on low manufacturing costs often leads to very large batch sizes and therefore indirectly to very long lead times for production.

If the choice of contract manufacturer is based solely on "cost", it is very easy to get caught up in a vicious circle of very large manufacturer lots, long replenishment cycles and the resulting lack of flexibility in production. Which company can predict the sales figures for the year after next with a high degree of certainty?

In most, if not all, companies, short-term rescheduling, changes in sales volumes in various markets due to regulatory changes or price changes, for example, or simply changes in the priority of products are the order of the day.

Overall, you are therefore usually better off with CMOs that can offer shorter replenishment times. Although the manufacturing costs are higher as a result, the risk of the goods already losing a large part of their value in the warehouse (due to the limited shelf life) is significantly reduced.

It often happens, for example, that packs have to be adapted due to regulatory changes. If you then still have large quantities of your product in stock because your contract manufacturer only produces competitively in very large batch sizes, you will of course make a large loss here.

Manufacturing costs, batch sizes, minimum order quantities, flexibility in production planning are a very delicate mix that has to be redefined for each product and each contract manufacturer.

When transferring an existing production to a new supplier, costs are incurred that are usually not directly attributed to the transfer but should be considered for the overall profitability. These include, for example, the costs of technical batches at the new supplier, the adaptation of the manufacturing method to the equipment and procedures of the contract manufacturer, costs for validations, costs for changing the registration dossier and the largest cost item:

the duration of the transfer project including the costs of all departments and persons involved. Costs are incurred twice during the project period. Once in the company's own production, which has not yet been transferred, and the total transfer costs including trials in the new production facility. This period in particular, together with the associated activities, is a key factor in determining the total costs of the production transfer and the success or failure of outsourcing.

It is therefore of paramount importance to plan such supply chain management projects carefully and implement them quickly. The difference between a quick, clean production transfer and a relatively complex, multi-year project could quickly exceed the million mark.

Outsourcing and technology transfer consulting

3. the production know-how is not available internally

You have developed a new product and now want to produce it. Establishing your own production facility, including constructing the necessary buildings, purchasing the equipment, etc., would take several years and require a massive investment of capital. Your only option is to find a competent contract manufacturer who can take over production. Here too, the manufacturer's price is not the all-important parameter, as it is more important to have solid development data that can also support the scale-up of the developed product, is analytically powerful and is also technologically proficient in making the necessary adjustments. These requirements are not met by all C(D)MOs. It is advisable to check carefully whether the promised technological expertise is actually available.

We advise you independently and represent your interests with suppliers and contract manufacturers.

Process validation

Good Practice Guide: Project Management for the Pharmaceutical Industry

What Does Contract Manufacturing Look Like In Pharma?

Many factory productions can be outsourced to contract manufacturers (CMs) in order for businesses to continue providing quality products to their customers in a cost-effective way, and so they can focus on other aspects of their business, increasing their overall productivity and efficiency, and improving their bottom line.

ment for the Pharmaceutical Industry | ISPE | International Society for Pharmaceutical Engineering

WordPress Cookie Plugin by Real Cookie Banner